Health in Niger 1,104 indicators covering health for Niger. IndicatorLatest Year10-yr change Rank Treatment success rate for patients treated for MDR-TB 72.0% 2022 down 16.3% 87th New leprosy case detection rate per 1 000 000 population 11.95 2024 down 45.0% 40th Treatment success rate: HIV-positive TB cases 78 2023 up 25.8% 61st Prevalence of wasting, weight for height 10.9% 2022 down 18.7% 8th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) i 83.0% 2025 — 109th International Health Regulations core capacity scores, SPAR version, 2 30 2025 — 139th Prevalence of underweight, weight for age 34.6% 2022 up 7.8% 2nd Leprosy registered prevalence rate per 1 000 000 population 11.13 2024 down 73.3% 46th Leprosy - Number of new leprosy cases among children 15 2024 up 150.0% 30th Leprosy - Number of cases registered for treatment 301 2024 down 61.1% 29th New leprosy child case detection rate (less than 15 years of age) per 1.19 2024 up 91.8% 44th Children (0-14) living with HIV 3,200 2024 down 37.3% 39th Ipv1 number unvaccinated 144,384 2023 down 75.9% 28th Children living with hiv 3,200 2024 down 37.3% 39th Contraceptive prevalence, any method 15.3% 2023 up 9.8% 112th Children (ages 0-14) newly infected with HIV 500 2024 unchanged 29th Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Number of children newly infected with hiv 500 2024 unchanged 29th Share of children under fifteen years old with hiv 406.88 2024 down 2.0% 33rd Number of female leprosy new cases 153 2024 down 11.0% 21st Estimated number of malaria deaths 35,478 2024 up 15.6% 3rd Estimated number of malaria cases 8.25 million 2024 up 4.7% 11th National smoking ban: NUMBER OF PLACES SMOKE-FREE 4 2022 unchanged 114th Contraceptive prevalence, any modern method 13.9% 2023 up 13.6% 108th Number of prevalent tuberculosis cases 30,000 2014 down 11.8% 45th Estimated malaria incidence 305.14 2024 down 25.6% 7th Estimated malaria mortality rate 131.24 2024 down 17.8% 1st Number of new G2D leprosy cases 52 2024 down 48.5% 21st Leprosy - New leprosy cases with G2D rate per 1 000 000 population 1.92 2024 down 63.5% 30th Inflation-adjusted prices for most sold brand of cigarettes: Prices in 2.07 2022 down 5.0% 171st Taxes as a % of price: total tax 36.0% 2022 up 16.5% 142nd Taxes as a % of price: value added tax 16.0% 2022 unchanged 42nd Taxes as a % of price: ad valorem excise 18.8% 2022 up 35.0% 64th Taxes as a % of price: specific excise 0.0% 2022 — 135th Taxes as a % of price: import duties 0.0% 2022 — 38th Taxes as a % of price: other taxes 1.3% 2022 up 23.3% 34th Vitamin A supplementation coverage rate 99.0% 2023 up 3.1% 1st Inflation-adjusted prices for most sold brand of cigarettes: Price in 500 2022 up 9.1% 45th Estimated number of children needing antiretroviral therapy based on W 3,300 2025 down 34.0% 38th Prevalence of severe wasting, weight for height 2.1% 2022 down 22.2% 14th Physical activity policies for activie societies 20 2023 unchanged 2nd Physical activity policies focused on active systems 10 2023 down 50.0% 101st Midwifery personnel 1,722 2023 up 106.0% 76th Number of deaths from malaria who 35,478 2024 up 15.6% 3rd Death rate from malaria 131.24 2024 down 17.8% 1st Incidence of malaria 305.14 2024 down 25.6% 7th Share of one year olds who received the final dose of pneumococcal vac 86 2024 up 561.5% 83rd Diphtheria tetanus pertussis vaccine vs pneumococcal vaccine coverage 86 2024 up 561.5% 83rd Estimated antiretroviral therapy coverage among children 37 2025 up 105.6% 63rd Death rate from poisonings 1.6 2021 up 14.3% 18th Rotavirus number unvaccinated 115,507 2023 down 82.1% 30th Share of deaths registered 10.1 2019 — 144th Prevalence of stunting, height for age 47.7% 2022 up 19.5% 3rd Affordability - percentage of GDP per capita required to purchase 2000 14.36 2022 down 3.1% 22nd Japanese encephalitis - number of reported cases 0 2025 — 19th Malaria cases reported 6.67 million 2024 up 68.3% 10th Deaths and missing persons due to natural disasters 0.15 2022 down 60.5% 87th Mean systolic blood pressure 133.3 2009 up 3.5% 6th Mean fasting blood glucose (mmol/l) 5.1 2009 up 2.0% 146th Number of pregnant women living with HIV who received antiretrovirals 982 2025 up 0.1% 42nd ← Previous Page 15 of 19 Next →